Affiliate of Cochrane, US, Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA.
Eur J Contracept Reprod Health Care. 2024 Oct;29(5):193-223. doi: 10.1080/13625187.2024.2373143. Epub 2024 Jul 15.
Contraceptive methods are well-established in their ability to prevent pregnancy and increase individual agency in childbearing. Evidence suggests that contraceptives can also be used to treat adverse conditions associated with menstruation, including abnormal and prolonged uterine bleeding, heavy menstrual bleeding, painful menstruation, endometriosis, uterine fibroids, and premenstrual dysphoric disorders.This review investigates the effects of contraceptive techniques such as contraceptive pills, and long-acting reversible contraceptives (e.g. intrauterine devices, implants) on menstrual morbidity.
Over ten databases with no geographical boundaries were searched from inception until October 2023. Study designs were one of the following types to be included: parallel or cluster randomised controlled trials, controlled clinical trials, controlled before and after studies, interrupted time series studies, cohort or longitudinal analyses, regression discontinuity designs, and case-control studies. Ten team members screened the papers in pairs with a Kappa score of more than 7, and Covidence was used. Conflicts were resolved by discussion, and the full papers were divided among the reviewers to extract the data from eligible studies.
Hormonal contraceptives are considered a well-tolerated, non-invasive, and clinically effective treatment for abnormal and prolonged uterine bleeding, heavy menstrual bleeding, painful menstruation, endometriosis, uterine fibroids, and premenstrual dysphoric disorders. Our studies investigating quality of life or well-being in women with heavy menstrual bleeding, endometriosis, or uterine fibroids have found improvements in all dimensions assessed.
Hormonal contraceptives significantly reduce pain, symptom severity, and abnormal bleeding patterns associated with women who suffer from heavy menstrual bleeding, endometriosis, and uterine fibroids.
避孕方法在预防怀孕和增强个体生育能力方面已经得到充分证实。有证据表明,避孕药具也可用于治疗与月经相关的不良状况,包括异常和延长的子宫出血、月经过多、痛经、子宫内膜异位症、子宫肌瘤和经前烦躁障碍。本综述调查了避孕方法(如避孕药和长效可逆避孕方法,如宫内节育器、植入物)对月经发病率的影响。
从成立到 2023 年 10 月,在十个无地域界限的数据库中进行了搜索。纳入的研究设计类型之一为:平行或集群随机对照试验、对照临床试验、对照前后研究、中断时间序列研究、队列或纵向分析、回归不连续设计和病例对照研究。十名团队成员成对筛选论文,Kappa 评分超过 7,使用 Covidence。通过讨论解决冲突,并将全文分配给审查员,以从合格研究中提取数据。
激素避孕药被认为是一种耐受性良好、非侵入性和临床有效的治疗方法,可治疗异常和延长的子宫出血、月经过多、痛经、子宫内膜异位症、子宫肌瘤和经前烦躁障碍。我们研究了患有月经过多、子宫内膜异位症或子宫肌瘤的女性的生活质量或幸福感,发现所有评估维度都有所改善。
激素避孕药可显著减轻患有月经过多、子宫内膜异位症和子宫肌瘤的女性的疼痛、症状严重程度和异常出血模式。